Keyphrases
Schizophrenic Patients
100%
Obsessive-compulsive Disorder
86%
Schizophrenia
75%
Platelets
48%
Peripheral-type Benzodiazepine Receptor
44%
Peripheral Benzodiazepine Receptor
43%
Benzodiazepine Receptor
39%
PK11195
33%
Cerebral Cortex
30%
Olanzapine
29%
Receptor Density
27%
Benzodiazepine Binding Site
27%
Imipramine
27%
Growth Hormone
26%
Benzodiazepines
26%
Israeli
26%
Posttraumatic Stress Disorder
25%
Antidepressants
22%
Diazepam
21%
Anxiety Disorders
20%
Healthy Controls
19%
Obsessive-compulsive Symptoms
19%
Kidney
18%
Risperidone
18%
Anorexia Nervosa
18%
Peripheral Component
18%
Antinociceptive
17%
Staircase Test
17%
Atypical Antipsychotics
16%
Patients with Schizophrenia
16%
Cytokine Production
16%
β-endorphin
16%
Haloperidol
16%
Swim Stress
15%
Schizo-obsessive Disorder
15%
GABAA Receptor (GABAAR)
15%
Serotonergic System
15%
Adolescent Patients
14%
High Affinity
14%
Clinical Characteristics
14%
Sexual Behavior
14%
Ligand-receptor Binding
14%
Central Benzodiazepine Receptor
14%
Clomipramine
14%
Placebo-controlled Study
14%
Functional Magnetic Resonance Imaging
13%
Major Depressive Disorder
13%
Depressed Patients
12%
Attention Deficit Disorder
12%
Serotonin Uptake
12%
Neuroscience
Obsessive-Compulsive Disorder
88%
Benzodiazepine Receptor
88%
Platelet
39%
Benzodiazepine
39%
Cerebral Cortex
31%
Binding Site
31%
Receptor
29%
Behavior (Neuroscience)
25%
Imipramine
23%
Antipsychotic
23%
Placebo
23%
Olanzapine
22%
Dopaminergic
21%
Posttraumatic Stress Disorder
21%
Antidepressant
19%
Anorexia Nervosa
18%
PK-11195
18%
Flumazenil
18%
Serotonergic
17%
Cytokine Production
16%
Bovine Somatotropin
16%
Growth Hormone
16%
Haloperidol
16%
Typical Antipsychotic
15%
Serotonin Transporter
15%
Major Depressive Disorder
14%
Clomipramine
14%
Functional Magnetic Resonance Imaging
13%
Hippocampus
13%
Negative Syndrome
12%
Endorphin
12%
5-HTTLPR
12%
Mental Disorder
11%
Clozapine
11%
Functional Connectivity
11%
Promoter Region
11%
Blood Plasma
10%
Diazepam
10%
Positive Syndrome
10%
Gamma-Aminobutyric Acid
10%
Risperidone
10%
Dopamine Transporter
9%
Interleukin 3
9%
Anxiety Disorder
9%
Cognitive Disorders
9%
Autism
9%
In Vitro
9%
Bipolar Disorder
9%
Behavioral Effect
9%
GABAA Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Benzodiazepine Receptor
60%
Benzodiazepine
43%
Receptor
38%
Antipsychotic
30%
Binding Site
29%
Olanzapine
24%
Diazepam
22%
Growth Hormone
22%
Prolactin
20%
Typical Antipsychotic
19%
Placebo
19%
Risperidone
18%
Antidepressant
17%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
14%
Placebo-Controlled Study
14%
Hydrocortisone
13%
Opiate Receptor
13%
Endorphin
12%
Methylphenidate
12%
Reboxetine
12%
Attention Deficit Disorder
11%
Atypical Antipsychotics
11%
Flumazenil
10%
4 Aminobutyric Acid
10%
Chlorpromazine
9%
Phenobarbital
9%
Mirtazapine
8%
Betahistine
8%
Akathisia
8%
Flunarizine
8%
Somatomedin C
8%
Fluoxetine
8%
Dopamine Transporter
8%
Tardive Dyskinesia
8%
Behavioral Effect
8%
Naloxone
7%
Side Effect
7%
Hyperactivity
7%
Antinociception
7%
Sexual Dysfunction
7%
Barbiturate
7%
Receptor Subtype
6%
Clonazepam
6%
Benzodiazepine Receptor Blocking Agent
6%
Alprazolam
6%
Dopamine Receptor Stimulating Agent
6%
Negative Syndrome
6%
Positive Syndrome
6%
Human Growth Hormone
6%
Serotonin
5%
